Levopront (Levodropropizine)

Levodropropizine is an antitussive that acts on the peripheral cough reflex pathway to relieve cough symptoms.

• Dry cough: Reduces frequency and intensity of non‑productive cough, providing symptomatic relief.
• Irritative cough: Alleviates cough triggered by throat irritation, helping improve comfort.
• Cough associated with mild respiratory infections: Helps control cough without central nervous system effects.

• Levodropropizine acts peripherally by inhibiting sensory nerve endings in the respiratory tract. This blockade reduces the afferent signals that trigger the cough reflex, leading to a decrease in cough frequency and intensity without affecting central nervous system pathways.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: Mild stomach upset may be reported.
• Dizziness: Transient light‑headedness in some patients.
• Headache: Occasional mild headache.
• Dry mouth: Reduced salivation leading to a dry sensation.
• Taste alteration: Slight change in taste perception.
• Somnolence: Mild drowsiness, especially at higher doses.

Serious or Rare Side Effects

• Allergic reaction: Rash, itching, or urticaria indicating hypersensitivity.
• Angioedema: Swelling of face, lips, or tongue requiring immediate medical attention.
• Hepatic dysfunction: Elevated liver enzymes in rare cases.
• Neutropenia: Decreased white blood cell count, increasing infection risk.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Anaphylaxis: Rapid onset of systemic allergic response, potentially life‑threatening.

When prescribing or dispensing Levopront, consider the following precautions.

• Assess patient history: Review for hypersensitivity to levodropropizine or other antitussives.
• Monitor hepatic function: Use cautiously in patients with liver disease.
• Use with caution in children: Follow pediatric dosing guidelines and monitor response.
• Avoid concomitant use with other central cough suppressants unless advised by a clinician.
• Pregnancy and lactation: Evaluate risk–benefit before prescribing.
• Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Levodropropizine has a limited interaction profile, but certain combinations require attention.

Major Interactions (Avoid)

• Combined use with other opioid‑containing antitussives: May increase risk of respiratory depression.
• Strong CYP3A4 inhibitors (if metabolized by this pathway): Potentially raise plasma levels of levodropropizine.
• MAO inhibitors: Caution due to theoretical risk of serotonin‑related effects.

Moderate Interactions (Monitor Closely)

• Alcohol: May enhance sedative effects and dizziness.
• Antihistamines: May increase antitussive effect, requiring dose adjustment.
• Bronchodilators: Monitor for additive effects on cough control.
• Herbal supplements (e.g., St. John’s wort): May alter metabolism, warranting observation.